CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 39,334	$ 25,009
Grant receivables	1,900	2,686
Prepaid expenses and other current assets	1,160	1,860
Restricted cash equivalents	489
Total current assets	42,883	29,555
Property and equipment, net	159	181
Right-of-use assets, operating leases	353	498
Total assets	43,395	30,234
Current liabilities:
Accounts payable	827	1,984
Accrued expenses	3,923	7,620
Deferred grant income, current	1,736	1,066
Operating lease liabilities, current	168	193
Other current liabilities		279
Total current liabilities	6,654	11,142
Operating lease liabilities, non-current	212	342
Total liabilities	6,866	11,484
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2025 and December 31, 2024
Common stock, $0.001 par value, 250,000,000 shares authorized; 88,268,078 and 59,854,877 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	88	60
Additional paid-in capital	231,745	193,850
Accumulated deficit	(195,304)	(175,160)
Total stockholders' equity	36,529	18,750
Total liabilities and stockholders' equity	$ 43,395	$ 30,234

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).